Close

Form SC 13D/A PERNIX THERAPEUTICS HOLD Filed by: Athyrium Opportunities Fund (A) LP

July 27, 2015 5:08 PM EDT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 3)*

 

 

Pernix Therapeutics Holdings, Inc.

(Name of Issuer)

Common Stock, par value $0.01 per share

(Title of Class of Securities)

71426V108

(CUSIP Number)

Andrew C. Hyman, Esq.

Athyrium Capital Management, LP

530 Fifth Avenue, Floor 25

New York, New York 10036

(212) 402-6925

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

July 22, 2015

(Date of Event Which Requires Filing of This Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ¨

 

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.

 

 

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


13D

CUSIP No. 71426V108   Page 2 of 20

 

  1   

Name of reporting person

 

Athyrium Opportunities Fund (A) LP

  2  

Check the appropriate box if a member of a group

(a)  ¨        (b)  x

 

  3  

SEC use only

 

  4  

Source of funds

 

OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

¨

  6  

Citizenship or place of organization

 

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

0

     8   

Shared voting power

 

2,447,239

     9   

Sole dispositive power

 

0

   10   

Shared dispositive power

 

2,447,239

11  

Aggregate amount beneficially owned by each reporting person

 

2,447,239

12  

Check box if the aggregate amount in Row (11) excludes certain shares

 

¨

13  

Percent of class represented by amount in Row (11)

 

4.91%

14  

Type of reporting person

 

PN

 

 


13D

CUSIP No. 71426V108   Page 3 of 20

 

  1   

Name of reporting person

 

Athyrium Opportunities Fund (B) LP

  2  

Check the appropriate box if a member of a group*

(a)  ¨        (b)  x

 

  3  

SEC use only

 

  4  

Source of funds

 

OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

¨

  6  

Citizenship or place of organization

 

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

0

     8   

Shared voting power

 

1,341,763

     9   

Sole dispositive power

 

0

   10   

Shared dispositive power

 

1,341,763

11  

Aggregate amount beneficially owned by each reporting person

 

1,341,763

12  

Check box if the aggregate amount in Row (11) excludes certain shares

 

¨

13  

Percent of class represented by amount in Row (11)

 

2.69%

14  

Type of reporting person

 

PN

 

 


13D

CUSIP No. 71426V108   Page 4 of 20

 

  1   

Name of reporting person

 

Athyrium Opportunities Associates LP

  2  

Check the appropriate box if a member of a group

(a)  ¨        (b)  x

 

  3  

SEC use only

 

  4  

Source of funds

 

OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

¨

  6  

Citizenship or place of organization

 

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

0

     8   

Shared voting power

 

3,789,002

     9   

Sole dispositive power

 

0

   10   

Shared dispositive power

 

3,789,002

11  

Aggregate amount beneficially owned by each reporting person

 

3,789,002

12  

Check box if the aggregate amount in Row (11) excludes certain shares

 

¨

13  

Percent of class represented by amount in Row (11)

 

7.6%

14  

Type of reporting person

 

PN

 


13D

CUSIP No. 71426V108 Page 5 of 20

 

  1 

Name of reporting person

 

Athyrium Opportunities Associates GP LLC

  2

Check the appropriate box if a member of a group

(a)  ¨        (b)  x

 

  3

SEC use only

 

  4

Source of funds

 

OO

  5

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

¨

  6

Citizenship or place of organization

 

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with

 

  7 

Sole voting power

 

0

  8

Shared voting power

 

3,789,002

  9

Sole dispositive power

 

0

10

Shared dispositive power

 

3,789,002

11

Aggregate amount beneficially owned by each reporting person

 

3,789,002

12

Check box if the aggregate amount in Row (11) excludes certain shares

 

¨

13

Percent of class represented by amount in Row (11)

 

7.6%

14

Type of reporting person

 

OO

 

 


13D

CUSIP No. 71426V108   Page 6 of 20

 

  1   

Name of reporting person

 

Athyrium Capital Management, LP

  2  

Check the appropriate box if a member of a group

(a)  ¨        (b)  x

 

  3  

SEC use only

 

  4  

Source of funds

 

OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

¨

  6  

Citizenship or place of organization

 

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

0

     8   

Shared voting power

 

3,789,002

     9   

Sole dispositive power

 

0

   10   

Shared dispositive power

 

3,789,002

11  

Aggregate amount beneficially owned by each reporting person

 

3,789,002

12  

Check box if the aggregate amount in Row (11) excludes certain shares

 

¨

13  

Percent of class represented by amount in Row (11)

 

7.6%

14  

Type of reporting person

 

PN / IA

 

 


13D

CUSIP No. 71426V108   Page 7 of 20

 

  1   

Name of reporting person

 

Athyrium Capital Holdings, LLC

  2  

Check the appropriate box if a member of a group

(a)  ¨        (b)  x

 

  3  

SEC use only

 

  4  

Source of funds

 

OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

¨

  6  

Citizenship or place of organization

 

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

0

     8   

Shared voting power

 

3,789,002

     9   

Sole dispositive power

 

0

   10   

Shared dispositive power

 

3,789,002

11  

Aggregate amount beneficially owned by each reporting person

 

3,789,002

12  

Check box if the aggregate amount in Row (11) excludes certain shares

 

¨

13  

Percent of class represented by amount in Row (11)

 

7.6%

14  

Type of reporting person

 

OO

 

 


13D

CUSIP No. 71426V108   Page 8 of 20

 

  1   

Name of reporting person

 

Jeffrey A. Ferrell

  2  

Check the appropriate box if a member of a group

(a)  ¨        (b)  x

 

  3  

SEC use only

 

  4  

Source of funds

 

OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

¨

  6  

Citizenship or place of organization

 

United States

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

0

     8   

Shared voting power

 

3,789,002

     9   

Sole dispositive power

 

0

   10   

Shared dispositive power

 

3,789,002

11  

Aggregate amount beneficially owned by each reporting person

 

3,789,002

12  

Check box if the aggregate amount in Row (11) excludes certain shares

 

¨

13  

Percent of class represented by amount in Row (11)

 

7.6%

14  

Type of reporting person

 

IN

 

 


13D

CUSIP No. 71426V108   Page 9 of 20

 

  1   

Name of reporting person

 

Athyrium Opportunities Advisers LLC

  2  

Check the appropriate box if a member of a group

(a)  ¨        (b)  x

 

  3  

SEC use only

 

  4  

Source of funds

 

OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

¨

  6  

Citizenship or place of organization

 

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

0

     8   

Shared voting power

 

3,789,002

     9   

Sole dispositive power

 

0

   10   

Shared dispositive power

 

3,789,002

11  

Aggregate amount beneficially owned by each reporting person

 

3,789,002

12  

Check box if the aggregate amount in Row (11) excludes certain shares

 

¨

13  

Percent of class represented by amount in Row (11)

 

7.6%

14  

Type of reporting person

 

OO / IA

 

 


13D

CUSIP No. 71426V108   Page 10 of 20

 

  1   

Name of reporting person

 

NB Alternatives Advisers LLC

  2  

Check the appropriate box if a member of a group

(a)  ¨        (b)  x

 

  3  

SEC use only

 

  4  

Source of funds

 

OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

¨

  6  

Citizenship or place of organization

 

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

0

     8   

Shared voting power

 

3,789,002

     9   

Sole dispositive power

 

0

   10   

Shared dispositive power

 

3,789,002

11  

Aggregate amount beneficially owned by each reporting person

 

3,789,002

12  

Check box if the aggregate amount in Row (11) excludes certain shares

 

¨

13  

Percent of class represented by amount in Row (11)

 

7.6%

14  

Type of reporting person

 

OO / IA

 

 


13D

CUSIP No. 71426V108   Page 11 of 20

 

  1   

Name of reporting person

 

NB Alternatives GP Holdings LLC

  2  

Check the appropriate box if a member of a group

(a)  ¨        (b)  x

 

  3  

SEC use only

 

  4  

Source of funds

 

OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

¨

  6  

Citizenship or place of organization

 

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

0

     8   

Shared voting power

 

3,789,002

     9   

Sole dispositive power

 

0

   10   

Shared dispositive power

 

3,789,002

11  

Aggregate amount beneficially owned by each reporting person

 

3,789,002

12  

Check box if the aggregate amount in Row (11) excludes certain shares

 

¨

13  

Percent of class represented by amount in Row (11)

 

7.6%

14  

Type of reporting person

 

OO

 

 


13D

CUSIP No. 71426V108 Page 12 of 20

 

  1 

Name of reporting person

 

NB Alternatives Holdings LLC

  2

Check the appropriate box if a member of a group

(a)  ¨        (b)  x

 

  3

SEC use only

 

  4

Source of funds

 

OO

  5

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

¨

  6

Citizenship or place of organization

 

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with

 

  7 

Sole voting power

 

0

  8

Shared voting power

 

3,789,002

  9

Sole dispositive power

 

0

10

Shared dispositive power

 

3,789,002

11

Aggregate amount beneficially owned by each reporting person

 

3,789,002

12

Check box if the aggregate amount in Row (11) excludes certain shares

 

¨

13

Percent of class represented by amount in Row (11)

 

7.6%

14

Type of reporting person

 

OO

 

 


13D

CUSIP No. 71426V108 Page 13 of 20

 

  1 

Name of reporting person

 

Neuberger Berman AA LLC

  2

Check the appropriate box if a member of a group

(a)  ¨        (b)  x

 

  3

SEC use only

 

  4

Source of funds

 

OO

  5

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

¨

  6

Citizenship or place of organization

 

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with

 

  7 

Sole voting power

 

0

  8

Shared voting power

 

3,789,002

  9

Sole dispositive power

 

0

10

Shared dispositive power

 

3,789,002

11

Aggregate amount beneficially owned by each reporting person

 

3,789,002

12

Check box if the aggregate amount in Row (11) excludes certain shares

 

¨

13

Percent of class represented by amount in Row (11)

 

7.6%

14

Type of reporting person

 

OO

 

 


13D

CUSIP No. 71426V108   Page 14 of 20

 

  1   

Name of reporting person

 

Neuberger Berman Group LLC

  2  

Check the appropriate box if a member of a group

(a)  ¨        (b)  x

 

  3  

SEC use only

 

  4  

Source of funds

 

OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

¨

  6  

Citizenship or place of organization

 

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

0

     8   

Shared voting power

 

3,789,002

     9   

Sole dispositive power

 

0

   10   

Shared dispositive power

 

3,789,002

11  

Aggregate amount beneficially owned by each reporting person

 

3,789,002

12  

Check box if the aggregate amount in Row (11) excludes certain shares

 

¨

13  

Percent of class represented by amount in Row (11)

 

7.6%

14  

Type of reporting person

 

OO


13D

CUSIP No. 71426V108   Page 15 of 20

 

This Amendment No. 3 amends the Schedule 13D filed with the SEC on May 1, 2015 by the Reporting Persons, as amended by Amendment No. 1 filed with the SEC on May 14, 2015 and as amended by Amendment No. 2 filed with the SEC on June 19, 2015, in respect of the common stock, par value $0.01 per share (“Common Stock”), of Pernix Therapeutics Holdings, Inc., a Maryland corporation (the “Company”). Unless otherwise indicated, each capitalized term used but not defined in this Amendment No. 3 shall have the meaning assigned to such term in the initial Schedule 13D.

Item 5. Interest in Securities of the Issuer.

Item 5 is hereby amended and restated in its entirety with the following:

(a)-(b) All calculations of percentage ownership in this Schedule 13D are based on 43,540,098 shares outstanding as of April 24, 2015, as reported in the Company’s Form 10-Q for the fiscal quarter ending on March 31, 2015 filed with the SEC on May 1, 2015, plus (i) the 2,842,289 shares of Common Stock received by the Funds on May 1, 2015; (ii) the 1,855,556 shares of Common Stock received by the Funds on May 27, 2015; (iii) the 1,430,965 shares of Common Stock received by the Funds on June 26, 2015 and (iv) an additional 181,781 shares of Common Stock which the Funds have the right to receive.

(1) Fund A directly beneficially owns or has a right to receive 2,447,239 shares of Common Stock (approximately 4.91% of the total number of shares of Common Stock outstanding). Fund A has the shared power to vote or direct the vote, and the shared power to dispose or direct the disposition of, all such 2,447,239 shares of Common Stock.

(2) Fund B directly beneficially owns or has a right to receive 1,341,763 shares of Common Stock (approximately 2.69% of the total number of shares of Common Stock outstanding). Fund B has the shared power to vote or direct the vote, and the shared power to dispose or direct the disposition of, all such 1,341,763 shares of Common Stock.

(3) Associates LP, in its capacity as the general partner of the Funds, has the ability to direct the management of the Funds’ business, including the power to vote and dispose of securities held by the Funds; therefore, Associates LP may be deemed to have indirect beneficial ownership of the 3,789,002 shares of Common Stock (approximately 7.6% of the total number of shares of Common Stock outstanding) beneficially owned by the Funds, collectively, and may be deemed to have shared voting and investment power over these shares of Common Stock.

(4) Associates GP, in its capacity as the general partner of Associates LP, has the ability to direct the management of Associates LP’s business and, as such, may indirectly control the decisions of Associates LP regarding the vote and disposition of securities beneficially owned by the Funds; therefore, Associates GP may be deemed to have indirect beneficial ownership of the 3,789,002 shares of Common Stock (approximately 7.6% of the total number of shares of Common Stock outstanding) beneficially owned by the Funds, collectively, and may be deemed to have shared voting and investment power over these shares of Common Stock.

(5) ACM, in its capacity as a member of Associates GP and an investment adviser to Opportunities Advisers, has the shared ability to direct the voting and disposal of securities held by the Funds; therefore, ACM may be deemed to have indirect beneficial ownership of the 3,789,002 shares of Common Stock (approximately 7.6% of the total number of shares of Common Stock outstanding) beneficially owned by the Funds, collectively, and may be deemed to have shared voting and investment power over these shares of Common Stock.

(6) ACH, in its capacity as the general partner of ACM has the ability to direct the management of ACM’s business and, as such, may indirectly control the decisions of ACM regarding the vote and disposition of securities held by the Funds; therefore, ACH may be deemed to have indirect beneficial ownership of the 3,789,002 shares of Common Stock (approximately 7.6% of the total number of shares of Common Stock outstanding) beneficially owned by the Funds, collectively, and may be deemed to have shared voting and investment power over these shares of Common Stock.

(7) Jeffrey A. Ferrell, in his capacity as the Managing Member of ACH, has the ability to direct the management of ACM’s business, including the power to vote and dispose of securities held by the Funds; therefore, Mr. Ferrell may be deemed to have indirect beneficial ownership of the 3,789,002 shares of Common Stock (approximately 7.6% of the total number of shares of Common Stock outstanding) beneficially owned by the Funds, collectively, and may be deemed to have shared voting and investment power over these shares of Common Stock.


13D

CUSIP No. 71426V108   Page 16 of 20

 

(8) Opportunities Advisers, in its capacity as an investment adviser to Associates GP, may have the shared ability to direct the voting and disposal of securities held by the Funds; therefore, Opportunities Advisers may be deemed to have indirect beneficial ownership of the 3,789,002 shares of Common Stock (approximately 7.6% of the total number of shares of Common Stock outstanding) beneficially owned by the Funds, collectively, and may be deemed to have shared voting and investment power over these shares of Common Stock.

(9) Alternatives Advisers, in its capacity as the sole member of Opportunities Advisers, may have the shared ability to direct the voting and disposal of securities held by the Funds; therefore, Alternatives Advisers may be deemed to have indirect beneficial ownership of the 3,789,002 shares of Common Stock (approximately 7.6% of the total number of shares of Common Stock outstanding) beneficially owned by the Funds, collectively, and may be deemed to have shared voting and investment power over these shares of Common Stock.

(10) Alternatives GP, in its capacity as a member of Associates GP, has the shared ability to direct the voting and disposal of securities held by the Funds; therefore, Alternatives GP may be deemed to have indirect beneficial ownership of the 3,789,002 shares of Common Stock (approximately 7.6% of the total number of shares of Common Stock outstanding) beneficially owned by the Funds, collectively, and may be deemed to have shared voting and investment power over these shares of Common Stock.

(11) Alternatives Holdings, in its capacity as the sole member of Alternatives GP and a member of Alternatives Advisers, has the shared ability to direct the voting and disposal of securities held by the Funds; therefore, Alternatives Holdings may be deemed to have indirect beneficial ownership of the 3,789,002 shares of Common Stock (approximately 7.6% of the total number of shares of Common Stock outstanding) beneficially owned by the Funds, collectively, and may be deemed to have shared voting and investment power over these shares of Common Stock.

(12) NB AA, in its capacity as a member of Alternatives Holdings and of Alternatives Advisers, has the shared ability to direct the voting and disposal of securities held by the Funds; therefore, NB AA may be deemed to have indirect beneficial ownership of the 3,789,002 shares of Common Stock (approximately 7.6% of the total number of shares of Common Stock outstanding) beneficially owned by the Funds, collectively, and may be deemed to have shared voting and investment power over these shares of Common Stock.

(13) NB Group, in its capacity as a member of Alternatives Holdings and the sole member of NB AA, has the shared ability to direct the voting and disposal of securities held by the Funds; therefore, NB Group may be deemed to have indirect beneficial ownership of the 3,789,002 shares of Common Stock (approximately 7.6% of the total number of shares of Common Stock outstanding) beneficially owned by the Funds, collectively, and may be deemed to have shared voting and investment power over these shares of Common Stock.

To the knowledge of the Reporting Persons, none of the Covered Persons directly owns any shares of Common Stock; provided, however, that because of each Covered Persons’ status as a director, executive officer, manager, member or partner of a Reporting Person, a Covered Person may be deemed to be the beneficial owner of the shares of Common Stock beneficially owned by such Reporting Person. Except to the extent of their pecuniary interest, each of the Covered Persons disclaims beneficial ownership of the shares of the Common Stock reported herein and the filing of this Schedule 13D shall not be construed as an admission that any such Covered Person is the beneficial owner of any securities covered by this statement.

(c) Except as set forth below, none of the Reporting Persons or, to their knowledge, none of the Covered Persons, has had any transactions in the Common Stock since the filing of Amendment No. 2 to the initial Schedule 13D.

On June 26, 2015, Fund A received 921,440 additional shares of Common Stock and Fund B received 509,525 additional shares of Common Stock from the Company.


13D

CUSIP No. 71426V108   Page 17 of 20

 

Since the filing of Amendment No. 2 to the initial Schedule 13D, the Funds have engaged in the following sales transactions on the NASDAQ Global Market:

 

Date

   Total Shares      Price      Fund A      Fund B  

7/7/2015

     170,000       $ 5.6868         109,468         60,532   

7/8/2015

     90,000       $ 5.4373         57,954         32,046   

7/9/2015

     57,600       $ 5.3979         37,090         20,510   

7/10/2015

     80,000       $ 5.3792         51,514         28,486   

7/13/2015

     102,400       $ 5.4039         65,938         36,462   

7/14/2015

     100,000       $ 5.4498         64,393         35,607   

7/15/2015

     75,000       $ 5.5127         48,295         26,705   

7/16/2015

     200,000       $ 6.0035         128,786         71,214   

7/17/2015

     115,000       $ 6.1051         74,052         40,948   

7/20/2015

     110,000       $ 5.6830         70,832         39,168   

7/21/2015

     100,000       $ 5.5649         64,393         35,607   

7/22/2015

     110,000       $ 5.4074         70,832         39,168   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

     1,310,000       $ 5.6400         843,547         466,453   

As of the date of this Amendment No. 3, the Funds have a right to receive a total of 181,781 additional shares of Common Stock.

(d) Except as set forth herein, to the knowledge of the Reporting Persons, no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, any shares of Common Stock.

(e) Not applicable.

 


13D

CUSIP No. 71426V108   Page 18 of 20

 

SIGNATURES

After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this Amendment No. 3 to Schedule 13D is true, complete and correct.

Dated as of July 27, 2015.

 

ATHYRIUM OPPORTUNITIES FUND (A) LP
  By:   ATHYRIUM OPPORTUNITIES ASSOCIATES LP, its General Partner
    By:   ATHYRIUM OPPORTUNITIES ASSOCIATES GP LLC, its General Partner
    By:   /s/ Christian Neira
    Name:   Christian Neira
    Title:   Authorized Signatory
ATHYRIUM OPPORTUNITIES FUND (B) LP
  By:   ATHYRIUM OPPORTUNITIES ASSOCIATES LP, its General Partner
    By:   ATHYRIUM OPPORTUNITIES ASSOCIATES GP LLC, its General Partner
    By:   /s/ Christian Neira
    Name:   Christian Neira
    Title:   Authorized Signatory
ATHYRIUM OPPORTUNITIES ASSOCIATES LP
  By:   ATHYRIUM OPPORTUNITIES ASSOCIATES GP LLC, its General Partner
  By:   /s/ Christian Neira
  Name:   Christian Neira
  Title:   Authorized Signatory


13D

CUSIP No. 71426V108   Page 19 of 20

 

ATHYRIUM OPPORTUNITIES ASSOCIATES GP LLC
By:   /s/ Christian Neira
Name:   Christian Neira
Title:   Authorized Signatory

ATHYRIUM CAPITAL MANAGEMENT, LP

By:   /s/ Jeffrey A. Ferrell
Name:   Jeffrey A. Ferrell
Title:   Authorized Signatory
ATHYRIUM CAPITAL HOLDINGS, LLC
By:   /s/ Jeffrey A. Ferrell
Name:   Jeffrey A. Ferrell
Title:   Authorized Signatory
/s/ Jeffrey A. Ferrell
JEFFREY A. FERRELL
ATHYRIUM OPPORTUNITIES ADVISERS LLC
  By:  

NB ALTERNATIVES ADVISERS LLC,

its Sole Member

  By:   /s/ Christian Neira
  Name:   Christian Neira
  Title:   Authorized Signatory
NB ALTERNATIVES ADVISERS LLC
By:   /s/ Christian Neira
Name:   Christian Neira
Title:   Authorized Signatory
NB ALTERNATIVES GP HOLDINGS LLC
By:   /s/ Christian Neira
Name:   Christian Neira
Title:   Authorized Signatory

 


13D

CUSIP No. 71426V108   Page 20 of 20

 

NB ALTERNATIVES HOLDINGS LLC
By:   /s/ Christian Neira
Name:   Christian Neira
Title:   Authorized Signatory

NEUBERGER BERMAN AA LLC

By:   /s/ Andrew Komaroff
Name:   Andrew Komaroff
Title:   Authorized Signatory

NEUBERGER BERMAN GROUP LLC

By:   /s/ Andrew Komaroff
Name:   Andrew Komaroff
Title:   Authorized Signatory


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings

Related Entities

13D